Addressing Resistance: Two New Treatment Options for Gonorrhea

Visit us on the Web Follow us on Twitter Visit us on Facebook Follow us on LinkedIn Addressing Resistance: Two New Treatment Options for Gonorrhea In the face of growing resistance to antibiotics against gonorrhea, scientists at the NIH and the Centers for Disease Control and Prevention recently completed a clinical trial testing two new treatment regimens combining existing, FDA-approved drugs. Both regimens successfully treated gonorrhea infections, the scientists announced earlier this week. However, they note, current treatment guidelines for gonorrhea will remain the same.  The findings were presented today at the 20th Meeting of the International Society for Sexually Transmitted Diseases Research. For more information on the new regimens and details of the trial results, see the NIAID press release: http://www.niaid.nih.gov/news/newsreleases/2013/Pages/GonorrheaTrial.aspx. Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to buzzhairs.health@blogger.com using GovDelivery, on behalf of: National Institute of Allergy and Infectious Diseases · 6610 Rockledge Drive · Bethesda, MD 20892 · 866-284-4107